Description: 4DMedical Limited operates as a software technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging platform that utilizes proven and patented mathematic models and algorithms to convert X-ray scans into quantitative data to enhance the capacity of physicians to manage patients with respiratory diseases and diseases of the lung. The company is also developing VQ (Perfusion), a diagnostic to scan and measure ventilation and perfusion; and Contrast Free Pulmonary Angiography (CFPA) products, as well as small animal ventilators and preclinical scanners. 4Dmedical Limited partners with University of Miami Health System to establish the functional lung imaging research program. The company was founded in 2012 and is based in Melbourne, Australia.
Home Page: 4dmedical.com
Melbourne Connect
Carlton,
VIC
3053
Australia
Phone:
61 3 9545 5940
Officers
Name | Title |
---|---|
Dr. Andreas Fouras M.A.I.C.D., Ph.D. | Founder, MD, CEO & Director |
Mr. Simon Glover | Chief Financial Officer |
Mr. John Andrew Livingston BAppSci, GradCertBus, GradDipHSc | Strategic Advisor & Executive Director |
Mr. Matt Tucker | Chief Commercial Officer |
Ms. Naomi Lawrie | Company Secretary & General Counsel |
Dr. Aidan Jamison B.E., Ph.D. | Senior Vice President of Engineering |
Ms. Rachael Tenkaten | Senior Vice President of Product |
Dr. Greg T. Mogel M.D. | Chief Medical Officer |
Mr. David Hannes B.S., M.B.A. | Senior Vice President of Global Business Development |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 3.0883 |
Price-to-Sales TTM: | 37.2429 |
IPO Date: | |
Fiscal Year End: | June |
Full Time Employees: | 145 |